|
1
|
Grimes DS: An epidemic of coronary heart
disease. QJM. 105:509–518. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hansson GK: Inflammation, atherosclerosis,
and coronary artery disease. N Engl J Med. 352:1685–1695. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Naghavi M, Libby P, Falk E, Casscells SW,
Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P,
Pasterkamp G, et al: From vulnerable plaque to vulnerable patient:
a call for new definitions and risk assessment strategies: Part I.
Circulation. 108:1664–1672. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Roman RM, Wendland AE and Polanczyk CA:
Myeloperoxidase and coronary arterial disease: From research to
clinical practice. Arq Bras Cardiol. 91:e11–e19. 2008.PubMed/NCBI
|
|
5
|
Morishita K, Tsuchiya M, Asano S, Kaziro Y
and Nagata S: Chromosomal gene structure of human myeloperoxidase
and regulation of its expression by granulocyte colony-stimulating
factor. J Biol Chem. 262:15208–15213. 1987.PubMed/NCBI
|
|
6
|
Piedrafita FJ, Molander RB, Vansant G,
Orlova EA, Pfahl M and Reynolds WF: An Alu element in the
myeloperoxidase promoter contains a composite SP1-thyroid
hormone-retinoic acid response element. J Biol Chem.
271:14412–14420. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pecoits-Filho R, Stenvinkel P, Marchlewska
A, Heimburger O, Bárány P, Hoff CM, Holmes CJ, Suliman M, Lindholm
B, Schalling M and Nordfors L: A functional variant of the
myeloperoxidase gene is associated with cardiovascular disease in
end-stage renal disease patients. Kidney Int Suppl. 84:S172–S176.
2003. View Article : Google Scholar
|
|
8
|
Davies MJ, Hawkins CL, Pattison DI and
Rees MD: Mammalian heme peroxidases: From molecular mechanisms to
health implications. Antioxid Redox Signal. 10:1199–1234. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hampton MB, Kettle AJ and Winterbourn CC:
Inside the neutrophil phagosome: Oxidants, myeloperoxidase, and
bacterial killing. Blood. 92:3007–3017. 1998.PubMed/NCBI
|
|
10
|
Verdecchia P, Angeli F, Cavallini C,
Mazzotta G, Garofoli M, Martire P and Reboldi G: The optimal blood
pressure target for patients with coronary artery disease. Curr
Cardiol Rep. 12:302–306. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cannon CP and Vierck E: The New Heart
Disease Handbook. 1st edition. Fair Winds Press; Beverly, MA:
2009
|
|
12
|
Sambrook J, Fritsch EF and Maniatis T:
Molecular Cloning - A Laboratory Manual. 2nd edition. Cold Spring
Harbor Laboratory Press; Cold Spring Harbor, NY: 1989
|
|
13
|
Arslan S, Pinarbasi H and Silig Y:
Myeloperoxidase G-463A polymorphism and risk of lung and prostate
cancer in a Turkish population. Mol Med Rep. 4:87–92.
2011.PubMed/NCBI
|
|
14
|
Lozano R, Naghavi M, Foreman K, Lim S,
Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et
al: Global and regional mortality from 235 causes of death for 20
age groups in 1990 and 2010: A systematic analysis for the Global
Burden of Disease Study 2010. Lancet. 380:2095–2128. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lusis AJ, Mar R and Pajukanta P: Genetics
of atherosclerosis. Annu Rev Genomics Hum Genet. 5:189–218. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Steinberg D and Witztum JL: Is the
oxidative modification hypothesis relevant to human
atherosclerosis? Do the antioxidant trials conducted to date refute
the hypothesis? Circulation. 105:2107–2111. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hillegass LM, Griswold DE, Brickson B and
Albrightson-Winslow C: Assessment of myeloperoxidase activity in
whole rat kidney. J Pharmacol Methods. 24:285–295. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nikpoor B, Turecki G, Fournier C, Théroux
P and Rouleau GA: A functional myeloperoxidase polymorphic variant
is associated with coronary artery disease in French-Canadians. Am
Heart J. 142:336–339. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zotova E, Lyrenäs L, de Faire U,
Morgenstern R, Gigante B and Bennet AM: The myeloperoxidase gene
and its influence on myocardial infarction in a Swedish population:
Protective role of the −129A allele in women. Coron Artery Dis.
20:322–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ergen A, İsbir S, Timirci Ö, Tekeli A and
İsbir T: Effects of myeloperoxidase −463 G/A gene polymorphism and
plasma levels on coronary artery disease. Mol Biol Rep. 38:887–891.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tang N, Wang Y and Mei Q: Myeloperoxidase
G-463A polymorphism and susceptibility to coronary artery disease:
A meta-analysis. Gene. 523:152–157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Borges FK, Borges FK, Stella SF, Souza JF,
Wendland AE, Werres Junior LC, Ribeiro JP and Polanczyk CA: Serial
analyses of C-reactive protein and myeloperoxidase in acute
coronary syndrome. Clin Cardiol. 32:E58–E62. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nicholls SJ and Hazen SL: Myeloperoxidase
and cardiovascular disease. Arterioscler Thromb Vasc Biol.
25:1102–1111. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Puddu P, Cravero E, Puddu GM and Muscari
A: Genes and atherosclerosis: At the origin of the predisposition.
Int J Clin Pract. 59:462–472. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mocatta TJ, Pilbrow AP, Cameron VA,
Senthilmohan R, Frampton CM, Richards AM and Winterbourn CC: Plasma
concentrations of myeloperoxidase predict mortality after
myocardial infarction. J Am Coll Cardiol. 49:1993–2000. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Meuwese MC, Stroes ES, Hazen SL, van Miert
JN, Kuivenhoven JA, Schaub RG, Wareham NJ, Luben R, Kastelein JJ,
Khaw KT and Boekholdt SM: Serum myeloperoxidase levels are
associated with the future risk of coronary artery disease in
apparently healthy individuals: The EPIC-Norfolk Prospective
Population Study. J Am Coll Cardiol. 50:159–165. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Finegold JA, Asaria P and Francis DP:
Mortality from ischaemic heart disease by country, region, and age:
Statistics from World Health Organisation and United Nations. Int J
Cardiol. 168:934–945. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Maddhuri S, Pallapolu P, Bandaru S, Suresh
G, Malempati AR, Jyothy A and Mundluru HP: Analysis of plasma
myeloperoxidase levels and functional gene −463G>A and
−129G>A polymorphisms with early onset of coronary artery
disease in South Indian population. Folia Cardiol. 11:272–278.
2016. View Article : Google Scholar
|
|
29
|
Li YY, Wang H, Qian J, Kim HJ, Wu JJ, Wang
LS, Zhou CW, Yang ZJ and Lu XZ: PRISMA-combined Myeloperoxidase
−463G/A gene polymorphism and coronary artery disease: A
meta-analysis of 4744 subjects. Medicine (Baltimore). 96:e64612017.
View Article : Google Scholar : PubMed/NCBI
|
